01 April 2010
- Medicines
n January 2010 the European Medicine Agency (EMA) made available the draft of its road map “The Agency’s Contribution to Science, Medicines and Health” for a public consultation which will last until the 30th of April. It sets out the Agency’s long term strategy taking into consideration the main drivers for change and the future challenges. The three strategic priority areas proposed are:  addressing public health needs, facilitating access to medicines, and optimising the safe use of medicines. It sets objectives for future action, notably taking into account patient experience to improve decision-making through and the safe use of medicines involving patient organisations. The EMA also intend to take into account the demands for more transparency through giving more information targeted for users such as patients. After the consultation the EMA will publish a new document “From vision to reality”, taking into account responses. EFA is going to respond to the consultation, and members will have an opportunity give feedback. For more information:

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team